Expression of PPP1R2 in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

PPP1R2 is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 25.91

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

22.3

Number of samples

141

Samples

Sample	Description	TPM
TCGA-14-1825-01A	0 years, male, white, stage:'--, dead, 232 days	49.2
TCGA-27-1834-01A	0 years, male, white, stage:'--, dead, 1233 days	43.8
TCGA-02-0047-01A	0 years, male, white, stage:'--, dead, 448 days	41.7
TCGA-27-1831-01A	0 years, male, white, stage:'--, dead, 505 days	39.1
TCGA-28-5216-01A	0 years, male, white, stage:'--, alive, 415 days	36.9
TCGA-14-1829-01A	0 years, male, black or african american, stage:'--, alive, 218 days	34.5
TCGA-06-5414-01A	0 years, male, white, stage:'--, alive, 273 days	33.7
TCGA-06-2558-01A	0 years, female, white, stage:'--, dead, 380 days	33.2
TCGA-32-5222-01A	0 years, male, white, stage:'--, dead, 585 days	33.1
TCGA-06-5411-01A	0 years, male, white, stage:'--, dead, 254 days	32.6
TCGA-28-2514-01A	0 years, male, asian, stage:'--, alive, 160 days	32.1
TCGA-41-3915-01A	0 years, male, white, stage:'--, dead, 360 days	31.9
TCGA-28-5215-01A	0 years, female, white, stage:'--, dead, 335 days	31.4
TCGA-14-0789-01A	0 years, male, white, stage:'--, dead, 342 days	30.2
TCGA-06-0644-01A	0 years, male, black or african american, stage:'--, dead, 384 days	30.2
TCGA-26-5133-01A	0 years, male, white, stage:'--, alive, 452 days	29.7
TCGA-32-2634-01A	0 years, male, white, stage:'--, alive, 693 days	29.3
TCGA-06-2562-01A	0 years, male, white, stage:'--, dead, 382 days	28.7
TCGA-27-2519-01A	0 years, male, white, stage:'--, dead, 550 days	28.5
TCGA-19-4065-01A	0 years, male, white, stage:'--, alive, 214 days	28.4
TCGA-12-3652-01A	0 years, male, white, stage:'--, dead, 1062 days	28.1
TCGA-41-4097-01A	0 years, female, white, stage:'--, dead, 6 days	27.8
TCGA-06-5418-01A	0 years, female, white, stage:'--, dead, 83 days	27.6
TCGA-28-2509-01A	0 years, female, white, stage:'--, alive, 145 days	27.3
TCGA-12-0618-01A	0 years, male, white, stage:'--, dead, 395 days	27.0
TCGA-06-5413-01A	0 years, male, white, stage:'--, alive, 268 days	26.8
TCGA-06-0878-01A	0 years, male, white, stage:'--, alive, 218 days	26.4
TCGA-26-1442-01A	0 years, male, white, stage:'--, alive, 953 days	26.2
TCGA-28-5207-01A	0 years, male, white, stage:'--, dead, 343 days	26.0
TCGA-27-1830-01A	0 years, male, white, stage:'--, dead, 154 days	25.8
TCGA-76-4931-01A	0 years, female, white, stage:'--, dead, 279 days	25.7
TCGA-27-1837-01A	0 years, male, white, stage:'--, dead, 427 days	25.5
TCGA-12-3653-01A	0 years, female, white, stage:'--, dead, 442 days	25.4
TCGA-12-5299-01A	0 years, female, white, stage:'--, dead, 98 days	25.3
TCGA-32-2616-01A	0 years, female, white, stage:'--, dead, 224 days	25.3
TCGA-26-5139-01A	0 years, female, white, stage:'--, alive, 48 days	25.2
TCGA-28-2513-01A	0 years, female, white, stage:'--, alive, 222 days	25.0
TCGA-06-0210-01A	0 years, female, white, stage:'--, dead, 225 days	25.0
TCGA-06-5410-01A	0 years, female, white, stage:'--, dead, 108 days	24.4
TCGA-06-5858-01A	0 years, female, white, stage:'--, alive, 187 days	24.3
TCGA-06-5416-01A	0 years, female, white, stage:'--, alive, 204 days	24.2
TCGA-19-2619-01A	0 years, female, black or african american, stage:'--, alive, 294 days	24.2
TCGA-32-1980-01A	0 years, male, white, stage:'--, dead, 36 days	24.0
TCGA-08-0386-01A	0 years, male, white, stage:'--, dead, 548 days	24.0
TCGA-06-0174-01A	0 years, male, white, stage:'--, dead, 98 days	24.0
TCGA-06-5412-01A	0 years, female, white, stage:'--, dead, 138 days	24.0
TCGA-12-0616-01A	0 years, female, white, stage:'--, dead, 448 days	23.8
TCGA-12-0619-01A	0 years, male, white, stage:'--, dead, 1062 days	23.6
TCGA-12-0821-01A	0 years, male, white, stage:'--, dead, 323 days	23.6
TCGA-06-2561-01A	0 years, female, white, stage:'--, dead, 537 days	23.6
TCGA-19-2629-01A	0 years, male, white, stage:'--, dead, 737 days	23.5
TCGA-06-0129-01A	0 years, male, asian, stage:'--, dead, 1024 days	23.4
TCGA-02-2486-01A	0 years, male, white, stage:'--, dead, 618 days	23.4
TCGA-06-0190-01A	0 years, male, white, stage:'--, dead, 317 days	23.3
TCGA-32-2638-01A	0 years, male, white, stage:'--, dead, 766 days	23.3
TCGA-14-2554-01A	0 years, female, white, stage:'--, dead, 532 days	23.2
TCGA-15-1444-01A	0 years, male, white, stage:'--, dead, 1537 days	23.1
TCGA-02-2483-01A	0 years, male, asian, stage:'--, alive, 466 days	23.0
TCGA-06-0238-01A	0 years, male, white, stage:'--, dead, 405 days	22.8
TCGA-32-2615-01A	0 years, male, white, stage:'--, dead, 485 days	22.8
TCGA-06-0646-01A	0 years, male, white, stage:'--, dead, 175 days	22.6
TCGA-76-4929-01A	0 years, female, white, stage:'--, dead, 111 days	22.5
TCGA-02-0055-01A	0 years, female, white, stage:'--, dead, 76 days	22.3
TCGA-06-2569-01A	0 years, female, black or african american, stage:'--, alive, 13 days	22.3
TCGA-06-5408-01A	0 years, female, white, stage:'--, dead, 357 days	22.2
TCGA-28-5208-01A	0 years, male, white, stage:'--, dead, 544 days	22.2
TCGA-14-1034-01A	0 years, female, stage:'--, dead, 485 days	22.1
TCGA-28-5209-01A	0 years, female, white, stage:'--, alive, 442 days	22.1
TCGA-06-0139-01A	0 years, male, white, stage:'--, dead, 362 days	22.1
TCGA-16-0846-01A	0 years, male, white, stage:'--, dead, 119 days	22.0
TCGA-06-0138-01A	0 years, male, white, stage:'--, dead, 737 days	21.9
TCGA-06-2564-01A	0 years, male, white, stage:'--, alive, 181 days	21.8
TCGA-76-4925-01A	0 years, male, white, stage:'--, dead, 146 days	21.7
TCGA-06-2559-01A	0 years, male, white, stage:'--, dead, 150 days	21.7
TCGA-19-2620-01A	0 years, male, white, stage:'--, dead, 148 days	21.7
TCGA-28-1753-01A	0 years, male, white, stage:'--, alive, 37 days	21.6
TCGA-06-0132-01A	0 years, male, white, stage:'--, dead, 771 days	21.6
TCGA-12-3650-01A	0 years, male, white, stage:'--, dead, 333 days	21.5
TCGA-06-0156-01A	0 years, male, white, stage:'--, dead, 178 days	21.3
TCGA-06-0130-01A	0 years, male, white, stage:'--, dead, 394 days	21.2
TCGA-06-0158-01A	0 years, male, white, stage:'--, dead, 329 days	21.0
TCGA-06-0187-01A	0 years, male, white, stage:'--, dead, 828 days	21.0
TCGA-14-0817-01A	0 years, female, white, stage:'--, dead, 164 days	21.0
TCGA-06-0211-01A	0 years, male, white, stage:'--, dead, 360 days	21.0
TCGA-06-0882-01A	0 years, male, white, stage:'--, dead, 632 days	20.9
TCGA-06-0686-01A	0 years, male, white, stage:'--, dead, 432 days	20.9
TCGA-28-5204-01A	0 years, male, white, stage:'--, dead, 454 days	20.8
TCGA-06-2570-01A	0 years, female, white, stage:'--, alive, 958 days	20.8
TCGA-06-5856-01A	0 years, male, white, stage:'--, dead, 114 days	20.7
TCGA-06-0125-01A	0 years, female, white, stage:'--, dead, 1448 days	20.7
TCGA-02-2485-01A	0 years, male, black or african american, stage:'--, alive, 470 days	20.7
TCGA-32-1982-01A	0 years, female, white, stage:'--, dead, 142 days	20.6
TCGA-27-2524-01A	0 years, male, white, stage:'--, dead, 231 days	20.2
TCGA-06-0157-01A	0 years, female, white, stage:'--, dead, 97 days	20.2
TCGA-06-0141-01A	0 years, male, white, stage:'--, dead, 313 days	20.0
TCGA-06-2557-01A	0 years, male, black or african american, stage:'--, dead, 33 days	19.9
TCGA-76-4932-01A	0 years, female, white, stage:'--, dead, 1458 days	19.9
TCGA-06-0184-01A	0 years, male, white, stage:'--, dead, 2126 days	19.8
TCGA-32-2632-01A	0 years, male, white, stage:'--, dead, 269 days	19.8
TCGA-06-0747-01A	0 years, male, white, stage:'--, dead, 82 days	19.2
TCGA-06-2567-01A	0 years, male, white, stage:'--, dead, 133 days	19.2
TCGA-06-0745-01A	0 years, male, white, stage:'--, dead, 239 days	19.1
TCGA-76-4927-01A	0 years, male, white, stage:'--, dead, 535 days	18.9
TCGA-06-0645-01A	0 years, female, white, stage:'--, dead, 175 days	18.8
TCGA-26-5132-01A	0 years, male, white, stage:'--, alive, 286 days	18.2
TCGA-14-1823-01A	0 years, female, white, stage:'--, dead, 543 days	18.2
TCGA-06-1804-01A	0 years, female, white, stage:'--, dead, 414 days	18.1
TCGA-32-1970-01A	0 years, male, white, stage:'--, dead, 468 days	18.1
TCGA-19-2624-01A	0 years, male, white, stage:'--, dead, 5 days	17.7
TCGA-06-2565-01A	0 years, male, asian, stage:'--, dead, 506 days	17.1
TCGA-41-5651-01A	0 years, female, black or african american, stage:'--, dead, 460 days	17.0
TCGA-32-4213-01A	0 years, female, white, stage:'--, alive, 604 days	16.9
TCGA-14-0787-01A	0 years, male, asian, stage:'--, dead, 68 days	16.7
TCGA-27-2526-01A	0 years, female, white, stage:'--, dead, 87 days	16.6
TCGA-15-0742-01A	0 years, male, white, stage:'--, dead, 419 days	16.4
TCGA-06-5417-01A	0 years, female, white, stage:'--, alive, 155 days	16.3
TCGA-41-2572-01A	0 years, male, white, stage:'--, dead, 406 days	16.2
TCGA-06-0750-01A	0 years, male, white, stage:'--, dead, 28 days	16.2
TCGA-06-0178-01A	0 years, male, white, stage:'--, dead, 2681 days	16.1
TCGA-28-5218-01A	0 years, male, white, stage:'--, dead, 157 days	15.8
TCGA-19-5960-01A	0 years, male, white, stage:'--, dead, 455 days	15.7
TCGA-12-5295-01A	0 years, female, white, stage:'--, dead, 454 days	15.6
TCGA-06-0749-01A	0 years, male, black or african american, stage:'--, dead, 82 days	15.4
TCGA-27-2523-01A	0 years, male, white, stage:'--, dead, 489 days	15.4
TCGA-28-5220-01A	0 years, male, white, stage:'--, dead, 388 days	15.2
TCGA-19-2625-01A	0 years, female, white, stage:'--, dead, 124 days	15.2
TCGA-06-0168-01A	0 years, female, white, stage:'--, dead, 598 days	15.2
TCGA-27-2521-01A	0 years, male, white, stage:'--, dead, 510 days	14.8
TCGA-06-5859-01A	0 years, male, white, stage:'--, alive, 139 days	14.8
TCGA-26-5135-01A	0 years, female, white, stage:'--, dead, 270 days	14.7
TCGA-27-1832-01A	0 years, female, white, stage:'--, dead, 300 days	14.6
TCGA-41-2571-01A	0 years, male, white, stage:'--, dead, 26 days	14.5
TCGA-06-2563-01A	0 years, female, white, stage:'--, alive, 932 days	14.2
TCGA-27-2528-01A	0 years, male, white, stage:'--, dead, 480 days	14.1
TCGA-19-1390-01A	0 years, female, white, stage:'--, dead, 772 days	13.6
TCGA-27-1835-01A	0 years, female, white, stage:'--, dead, 648 days	12.7
TCGA-06-0744-01A	0 years, male, white, stage:'--, dead, 1426 days	12.6
TCGA-06-0219-01A	0 years, male, white, stage:'--, dead, 22 days	12.5
TCGA-06-0743-01A	0 years, male, white, stage:'--, dead, 803 days	10.6
TCGA-14-0871-01A	0 years, female, white, stage:'--, dead, 880 days	10.3
TCGA-26-5134-01A	0 years, male, white, stage:'--, alive, 167 days	7.8
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

PPP1R2 is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 15.05

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

13.5

Number of samples

Samples

Sample	Description	TPM
AK205	N, NA, stage:NA, dead, 120 days	24.0
AK183	N, NA, stage:NA, alive, 360 days	22.6
AK051	N, NA, stage:NA, dead, 360 days	21.1
AK178	N, NA, stage:NA, dead, 240 days	20.8
AK156	N, NA, stage:NA, dead, 330 days	20.8
AK099	N, NA, stage:NA, dead, 420 days	19.5
AK117	N, NA, stage:NA, dead, 210 days	17.7
AK003	N, NA, stage:NA, dead, 600 days	17.3
AK173	N, NA, stage:NA, dead, 180 days	17.0
AK153	N, NA, stage:NA, dead, 240 days	16.2
AK068	N, NA, stage:NA, alive, 360 days	15.8
AK199	N, NA, stage:NA, alive, 1860 days	15.7
AK231	N, NA, stage:NA, dead, 240 days	15.7
AK071	N, NA, stage:NA, dead, 540 days	15.4
AK002	N, NA, stage:NA, dead, 570 days	15.3
AK049	N, NA, stage:NA, dead, 180 days	15.2
AK149	N, NA, stage:NA, dead, 420 days	15.2
AK124	N, NA, stage:NA, alive, 1920 days	14.9
AK227	N, NA, stage:NA, alive, 300 days	14.9
AK066	N, NA, stage:NA, alive, 960 days	14.8
AK015	N, NA, stage:NA, alive, 720 days	14.6
AK213	N, NA, stage:NA, alive, 2010 days	14.2
AK216	N, NA, stage:NA, dead, 360 days	14.2
AK142	N, NA, stage:NA, alive, 90 days	14.1
AK139	N, NA, stage:NA, dead, 270 days	14.1
AK218	N, NA, stage:NA, dead, 180 days	13.8
AK158	N, NA, stage:NA, dead, 360 days	13.8
AK195	N, NA, stage:NA, dead, 390 days	13.6
AK074	N, NA, stage:NA, alive, 300 days	13.4
AK006	N, NA, stage:NA, dead, 360 days	12.7
AK079	N, NA, stage:NA, dead, 210 days	12.5
AK091	N, NA, stage:NA, dead, 210 days	12.4
AK053	N, NA, stage:NA, dead, 300 days	12.4
AK236	N, NA, stage:NA, dead, 360 days	12.3
AK041	N, NA, stage:NA, alive, 810 days	12.2
AK005	N, NA, stage:NA, dead, 240 days	11.9
AK134	N, NA, stage:NA, dead, 360 days	11.8
AK085	N, NA, stage:NA, alive, 660 days	11.6
AK133	N, NA, stage:NA, dead, 360 days	11.4
AK043	N, NA, stage:NA, alive, 660 days	11.4
AK165	N, NA, stage:NA, alive, 360 days	11.3
AK103	N, NA, stage:NA, alive, 1320 days	11.0
AK098	N, NA, stage:NA, dead, 660 days	11.0
AK188	N, NA, stage:NA, alive, 420 days	10.8
AK030	N, NA, stage:NA, dead, 120 days	10.7
AK072	N, NA, stage:NA, dead, 150 days	10.6
AK167	N, NA, stage:NA, dead, 180 days	10.4
AK076	N, NA, stage:NA, alive, 660 days	10.3
AK089	N, NA, stage:NA, dead, 330 days	10.3
AK081	N, NA, stage:NA, dead, 180 days	10.2
AK100	N, NA, stage:NA, alive, 960 days	9.8
AK055	N, NA, stage:NA, dead, 240 days	9.6
AK226	N, NA, stage:NA, dead, 360 days	9.4
AK102	N, NA, stage:NA, alive, 1740 days	8.8
AK123	N, NA, stage:NA, dead, 180 days	8.4
AK088	N, NA, stage:NA, dead, 360 days	8.1
AK035	N, NA, stage:NA, dead, 210 days	7.3
AK185	N, NA, stage:NA, alive, 330 days	6.5
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0204400003	Normal	1.1
CPT0204380003	Normal	0.7
CPT0204420003	Normal	0.7
CPT0204370003	Normal	0.7
CPT0217880003	Tumor	0.6
CPT0204390003	Normal	0.6
CPT0204410003	Normal	0.5
CPT0204340003	Normal	0.5
CPT0204330003	Normal	0.5
CPT0209440003	Tumor	0.4
CPT0125510003	Tumor	0.4
CPT0207090003	Tumor	0.4
CPT0204360003	Normal	0.4
CPT0199770003	Tumor	0.4
CPT0206330003	Tumor	0.3
CPT0225760003	Tumor	0.3
CPT0205890003	Tumor	0.3
CPT0168480003	Tumor	0.3
CPT0204350003	Normal	0.3
CPT0175060003	Tumor	0.3
CPT0218670003	Tumor	0.2
CPT0127480003	Tumor	0.2
CPT0206670004	Tumor	0.2
CPT0186100003	Tumor	0.2
CPT0224540004	Tumor	0.2
CPT0189750004	Tumor	0.2
CPT0206000004	Tumor	0.2
CPT0161730003	Tumor	0.1
CPT0182580003	Tumor	0.1
CPT0206450003	Tumor	0.1
CPT0093450003	Tumor	0.1
CPT0168270003	Tumor	0.1
CPT0196850003	Tumor	0.1
CPT0218330004	Tumor	0.1
CPT0190240004	Tumor	0.1
CPT0189250003	Tumor	0.1
CPT0225730003	Tumor	0.1
CPT0168720003	Tumor	0.1
CPT0189650004	Tumor	0.1
CPT0104220003	Tumor	0.1
CPT0182550003	Tumor	0.1
CPT0228220003	Tumor	0.1
CPT0002410011	Tumor	0.1
CPT0168830003	Tumor	0.1
CPT0218690004	Tumor	0.1
CPT0206560003	Tumor	0.1
CPT0224330003	Tumor	0.1
CPT0093360003	Tumor	0.1
CPT0205450004	Tumor	0.0
CPT0167970003	Tumor	0.0
CPT0162020003	Tumor	0.0
CPT0064650003	Tumor	0.0
CPT0087680003	Tumor	0.0
CPT0218890004	Tumor	0.0
CPT0071100003	Tumor	0.0
CPT0217710008	Tumor	0.0
CPT0171580008	Tumor	0.0
CPT0087730003	Tumor	0.0
CPT0205670004	Tumor	0.0
CPT0093510003	Tumor	0.0
CPT0125570003	Tumor	0.0
CPT0205570003	Tumor	0.0
CPT0207030003	Tumor	0.0
CPT0089150003	Tumor	0.0
CPT0216920008	Tumor	0.0
CPT0218770003	Tumor	0.0
CPT0218830004	Tumor	-0.1
CPT0104330003	Tumor	-0.1
CPT0217430008	Tumor	-0.1
CPT0125220003	Tumor	-0.1
CPT0182500003	Tumor	-0.1
CPT0208980003	Tumor	-0.1
CPT0168590003	Tumor	-0.1
CPT0092440003	Tumor	-0.1
CPT0217060003	Tumor	-0.1
CPT0079790003	Tumor	-0.1
CPT0224390004	Tumor	-0.1
CPT0190360004	Tumor	-0.1
CPT0201710003	Tumor	-0.1
CPT0167640003	Tumor	-0.1
CPT0218960004	Tumor	-0.1
CPT0221180003	Tumor	-0.1
CPT0167860004	Tumor	-0.2
CPT0078580003	Tumor	-0.2
CPT0123530003	Tumor	-0.2
CPT0206110003	Tumor	-0.2
CPT0167530003	Tumor	-0.2
CPT0224600003	Tumor	-0.2
CPT0189850004	Tumor	-0.2
CPT0206880003	Tumor	-0.3
CPT0127420003	Tumor	-0.3
CPT0162140003	Tumor	-0.3
CPT0205780003	Tumor	-0.3
CPT0189460003	Tumor	-0.3
CPT0093590003	Tumor	-0.3
CPT0093550003	Tumor	-0.3
CPT0219080004	Tumor	-0.3
CPT0217100003	Tumor	-0.3
CPT0206780003	Tumor	-0.3
CPT0087950003	Tumor	-0.4
CPT0168380003	Tumor	-0.4
CPT0087570003	Tumor	-0.4
CPT0064890003	Tumor	-0.4
CPT0189570004	Tumor	-0.4
CPT0217190003	Tumor	-0.4
CPT0167750004	Tumor	-0.4
CPT0168080003	Tumor	-0.4
CPT0217000004	Tumor	-0.8
CPT0206230003	Tumor	-0.9
CPT0162100003	Tumor	-1.0
Show allShow less

GLIOMA - Protein expressionⁱ

Pending cancer tissue analysis